Ares Aerospacial e Defensa is a Brazilian arms company which has operated since 2010 as a subsidiary company of the Israeli defense company Elbit Systems Ltd.
Ares' website states that it "concentrates its activities in the planning, design, development, manufacture, integration, maintenance and commercialization of products in three main lines of business: Stations of Arms, Naval Systems, Optical and Electro-Optical."[1]
In 2017, Ares Aeroespacial e Defesa signed a $100 million contract to supply the Brazilian Armed Forces with remote-controlled weapon systems (RCWS).[2] According to Defense Update, "The RCWS, named REMAX, will be supplied over a five-year period", and "will be used in armored vehicles and logistics vehicles utilized in combat for troop transport, border patrol and peace keeping missions."[3]
Bezhalel Machlis, the president and CEO of Elbit Systems, said: "Brazil is a very important market for Elbit Systems and we are pleased to be awarded a follow-on contract for the supply of Remax to the Brazilian Army."[4]
In 2018, Ares installed an Atena electro-optical infrared surveillance system to the Niterói-class Brazilian Navy frigate Defensora.[5] Naval.com.br noted that the work "could lead to the installation of the system in the other frigates Niterói (F40), Constitution (F42), Liberal (F43), Independence (F44) and Union (F45)."[6]
References
- Empresa ares.ind.br, retrieved 2019-02-16^
- Shoshanna Solomon. Israel's Elbit gets Brazil contract for $100 million The Times of Israel, retrieved 2019-02-16^
- Tamir Eshel. Elbit Systems' Subsidiary to Produce Remote Weapon Stations in Brazil Defense Update, 2017-01-08, retrieved 2019-02-16^
- Ares wins Brazil RCWS contract - LWI - Land Warfare - Shephard Media www.shephardmedia.com, retrieved 2019-02-16^
- Headlines – October 17, 2018 www.aerotechnews.com, 17 October 2018, retrieved 2019-02-16^
- Israel Figueiredo Jr, Mauricio Afonso Vericimo, Sergio Carmona São Clemente, Gerlinde Platais Brasil Teixeira. Anti-Anisakis antibodies in human umbilical cord blood Pediatria I Medycyna Rodzinna, 2018-10-31^